Emergent BioSolutions Book Value Per Share Growth & History (EBS)
Emergent BioSolutions's book value per share was $10.03 for fiscal 2025.
View full Emergent BioSolutions company overviewEmergent BioSolutions annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $10.03 | $1.14 | +12.81% |
| 2024 | 2024-12-31 | $8.89 | -$3.55 | −28.52% |
| 2023 | 2023-12-31 | $12.44 | -$15.26 | −55.09% |
| 2022 | 2022-12-31 | $27.70 | -$3.71 | −11.83% |
| 2021 | 2021-12-31 | $31.41 | $4.09 | +14.97% |
| 2020 | 2020-12-31 | $27.32 | $6.22 | +29.45% |
| 2019 | 2019-12-31 | $21.11 | $1.36 | +6.91% |
| 2018 | 2018-12-31 | $19.74 | $1.28 | +6.91% |
| 2017 | 2017-12-31 | $18.47 | $3.77 | +25.68% |
| 2016 | 2016-12-31 | $14.69 | -$2.05 | −12.27% |
| 2015 | 2015-12-31 | $16.75 | $2.08 | +14.17% |
| 2014 | 2014-12-31 | $14.67 | $1.30 | +9.73% |
| 2013 | 2013-12-31 | $13.37 | $1.06 | +8.65% |
| 2012 | 2012-12-31 | $12.30 | $0.80 | +6.94% |
| 2011 | 2011-12-31 | $11.51 | $0.95 | +9.03% |
| 2010 | 2010-12-31 | $10.55 | $2.54 | +31.77% |
| 2009 | 2009-12-31 | $8.01 | — | — |
Emergent BioSolutions quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $6.65 | -$3.33 | −33.35% |
| Q1 2026 | 2026-03-31 | $10.10 | -$0.04 | −0.42% |
| Q4 2025 | 2025-12-31 | $10.03 | $1.14 | +12.81% |
| Q3 2025 | 2025-09-30 | $11.05 | $1.66 | +17.62% |
| Q2 2025 | 2025-06-30 | $9.99 | $2.68 | +36.74% |
| Q1 2025 | 2025-03-31 | $10.14 | -$2.53 | −19.96% |
| Q4 2024 | 2024-12-31 | $8.89 | -$3.55 | −28.52% |
| Q3 2024 | 2024-09-30 | $9.40 | -$4.06 | −30.18% |
| Q2 2024 | 2024-06-30 | $7.30 | -$11.19 | −60.50% |
| Q1 2024 | 2024-03-31 | $12.67 | -$11.22 | −46.97% |
| Q4 2023 | 2023-12-31 | $12.44 | -$15.26 | −55.09% |
| Q3 2023 | 2023-09-30 | $13.46 | -$15.26 | −53.13% |
| Q2 2023 | 2023-06-30 | $18.49 | -$11.74 | −38.83% |
| Q1 2023 | 2023-03-31 | $23.89 | -$7.37 | −23.56% |
| Q4 2022 | 2022-12-31 | $27.70 | -$3.71 | −11.83% |
| Q3 2022 | 2022-09-30 | $28.72 | $0.36 | +1.28% |
| Q2 2022 | 2022-06-30 | $30.23 | $1.48 | +5.15% |
| Q1 2022 | 2022-03-31 | $31.26 | $2.85 | +10.02% |
| Q4 2021 | 2021-12-31 | $31.41 | $4.09 | +14.97% |
| Q3 2021 | 2021-09-30 | $28.36 | $4.74 | +20.08% |
| Q2 2021 | 2021-06-30 | $28.75 | $6.09 | +26.85% |
| Q1 2021 | 2021-03-31 | $28.41 | $7.86 | +38.25% |
| Q4 2020 | 2020-12-31 | $27.32 | $6.22 | +29.45% |
| Q3 2020 | 2020-09-30 | $23.61 | $3.56 | +17.72% |
| Q2 2020 | 2020-06-30 | $22.66 | $3.50 | +18.25% |
| Q1 2020 | 2020-03-31 | $20.55 | $1.34 | +6.99% |
| Q4 2019 | 2019-12-31 | $21.11 | $1.36 | +6.91% |
| Q3 2019 | 2019-09-30 | $20.06 | $0.80 | +4.14% |
| Q2 2019 | 2019-06-30 | $19.16 | $0.40 | +2.14% |
| Q1 2019 | 2019-03-31 | $19.21 | $1.51 | +8.56% |
| Q4 2018 | 2018-12-31 | $19.74 | $1.28 | +6.91% |
| Q3 2018 | 2018-09-30 | $19.26 | $3.22 | +20.09% |
| Q2 2018 | 2018-06-30 | $18.76 | $3.67 | +24.28% |
| Q1 2018 | 2018-03-31 | $17.69 | $2.79 | +18.71% |
| Q4 2017 | 2017-12-31 | $18.47 | $3.77 | +25.68% |
| Q3 2017 | 2017-09-30 | $16.04 | $2.51 | +18.58% |
| Q2 2017 | 2017-06-30 | $15.10 | -$1.54 | −9.26% |
| Q1 2017 | 2017-03-31 | $14.90 | -$1.84 | −10.98% |
| Q4 2016 | 2016-12-31 | $14.69 | -$2.05 | −12.27% |
| Q3 2016 | 2016-09-30 | $13.53 | -$2.04 | −13.11% |
| Q2 2016 | 2016-06-30 | $16.64 | $2.13 | +14.65% |
| Q1 2016 | 2016-03-31 | $16.74 | $2.71 | +19.30% |
| Q4 2015 | 2015-12-31 | $16.75 | $2.08 | +14.17% |
| Q3 2015 | 2015-09-30 | $15.57 | $1.90 | +13.91% |
| Q2 2015 | 2015-06-30 | $14.51 | $1.50 | +11.49% |
| Q1 2015 | 2015-03-31 | $14.03 | $1.24 | +9.65% |
| Q4 2014 | 2014-12-31 | $14.67 | $1.30 | +9.73% |
| Q3 2014 | 2014-09-30 | $13.67 | $0.80 | +6.19% |
| Q2 2014 | 2014-06-30 | $13.02 | $0.59 | +4.78% |
| Q1 2014 | 2014-03-31 | $12.80 | $0.74 | +6.13% |
| Q4 2013 | 2013-12-31 | $13.37 | $1.06 | +8.65% |
| Q3 2013 | 2013-09-30 | $12.87 | $1.05 | +8.91% |
| Q2 2013 | 2013-06-30 | $12.42 | $0.83 | +7.16% |
| Q1 2013 | 2013-03-31 | $12.06 | $0.73 | +6.47% |
| Q4 2012 | 2012-12-31 | $12.30 | $0.80 | +6.94% |
| Q3 2012 | 2012-09-30 | $11.82 | $1.19 | +11.16% |
| Q2 2012 | 2012-06-30 | $11.59 | $1.07 | +10.16% |
| Q1 2012 | 2012-03-31 | $11.33 | — | — |
| Q4 2011 | 2011-12-31 | $11.51 | $0.95 | +9.03% |
| Q3 2011 | 2011-09-30 | $10.63 | — | — |
| Q2 2011 | 2011-06-30 | $10.52 | — | — |
| Q4 2010 | 2010-12-31 | $10.55 | — | — |
Emergent BioSolutions book value per share trends
Over the last five fiscal years, Emergent BioSolutions's book value per share decreased from $27.32 to $10.03, a change of -$17.29. The latest reported quarter, Q2 2026, shows $6.65.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Emergent BioSolutions source filings ↗